Serotonin and Dopamine protect from Hypothermia/rewarming damage through the CBS/ H 2S pathway

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Talaei, Fatemeh ^a   Bouma, Hjalmar ^a   van der Graaf, Adrianus ^b   Strijkstra, Arjen ^a,c   Schmidt, Martina ^c   Henning, Robert ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Angteq BV   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; CASPASE; CYSTATHIONINE BETA SYNTHASE; DOPAMINE; HYDROGEN SULFIDE; MAMMALIAN TARGET OF RAPAMYCIN; PYRIDOXAL 5 PHOSPHATE; REACTIVE OXYGEN METABOLITE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SEROTONIN; SMALL INTERFERING RNA; DOPAMINE RECEPTOR STIMULATING AGENT; SEROTONIN AGONIST;

ACIDOSIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HEART MUSCLE; HUMAN; HUMAN CELL; HYPOTHERMIA; HYPOXEMIA; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LUNG PARENCHYMA; MALE; NONHUMAN; PH MEASUREMENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; WARMING; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HAMSTER; KIDNEY; MESANGIUM CELL; METABOLISM; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

MAMMALIA; RATTUS;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CRICETINAE; CYSTATHIONINE BETA-SYNTHASE; DOPAMINE; DOPAMINE AGENTS; HUMANS; HYDROGEN SULFIDE; HYPOTHERMIA; KIDNEY; MALE; MESANGIAL CELLS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REWARMING; RNA, SMALL INTERFERING; SEROTONIN; SEROTONIN RECEPTOR AGONISTS; SIGNAL TRANSDUCTION;

EID: 79960799357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022568     Document Type: Article

References (51)

1. Dorweiler B, Pruefer D, Andrasi T, Maksan S, Schmiedt W, et al. (2007) Ischemia-reperfusion injury. Eur J Trauma Emerg S 33: 600-612.
2. Becker LB, (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61: 461-470.
3. Simon HU, Haj-Yehia A, Levi-Schaffer F, (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5: 415-418.
4. Boutilier RG, (2001) Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 204: 3171-3181.
5. Rauen U, de Groot H, (2002) Mammalian cell injury induced by hypothermia- the emerging role for reactive oxygen species. Biol Chem 383: 477-488.
6. Yard B, Beck G, Schnuelle P, Braun C, Schaub M, et al. (2004) Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds. Am J Transplant 4: 22-30.
7. Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, et al. (2009) Effects of donor pretreatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA 302: 1067-1075.
8. Hosoki R, Matsuki N, Kimura H, (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531.
9. Calvert JW, Coetzee WA, Lefer DJ, (2010) Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid Redox Signal 12: 1203-1217.
10. Frank N, Kent JO, Meier M, Kraus JP, (2008) Purification and characterization of the wild type and truncated human cystathionine beta-synthase enzymes expressed in E. coli. Arch Biochem Biophys 470: 64-72.
11. Taoka S, Ohja S, Shan X, Kruger WD, Banerjee R, (1998) Evidence for heme-mediated redox regulation of human cystathionine β-synthase activity. J Biol Chem 273: 25179-25184.
12. LaBella FS, Brandes LJ, (2000) Interaction of histamine and other bioamines with cytochromes P450: Implications for cell growth modulation and chemopotentiation by drugs. Semin Cancer Biol 10: 47-53.
13. Stipanuk MH, Beck PW, (1982) Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206: 267-277.
14. Zhao W, Zhang J, Lu Y, Wang R, (2001) The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20: 6008-6016.
15. Sola A, Palacios L, Lopez-Marti J, Ivorra A, Noguera N, et al. (2003) Multiparametric monitoring of ischemia-reperfusion in rat kidney: Effect of ischemic preconditioning. Transplantation 75: 744-749.
16. Wang X, Proud CG, (2006) The mTOR pathway in the control of protein synthesis. Physiology 21: 362-369.
17. Scott JW, Hawley SA, Green KA, Anis M, Stewart G, et al. (2004) CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 113: 274-284.
18. Janosik M, Kery V, Gaustadnes M, Maclean KN, Kraus JP, (2001) Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: Evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry (N Y) 40: 10625-10633.
19. Betten A, Dahlgren C, Hermodsson S, Hellstrand K, (2001) Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol 70: 65-72.
20. Fuenmayor L, Gomez J, Campos HA, Romero E, (1976) Presence of serotonin in the rat vas deferens: Its influence on contractile responses. Neuroscience 1: 197-203.
21. Celuch SM, Sloley BD, (1988) Regional distribution of dopamine, 5-hydroxytryptamine, and noradrenaline in the rat vas deferens. Neurochem Res 13: 967-972.
22. Szabo C, (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935.
23. Haouzi P, Notet V, Chenuel B, Chalon B, Sponne I, et al. (2008) H2S induced hypometabolism in mice is missing in sedated sheep. Respir Physiol Neurobiol 160: 109-115.
24. Drabek T, Kochanek PM, Stezoski J, Wu X, Bayr H, et al. (2011) Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock 35: 67-73.
25. Osipov RM, Robich MP, Feng J, Liu Y, Clements RT, et al. (2009) Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: Comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 54: 287-297.
26. Brinkkoetter PT, Song H, Losel R, Schnetzke U, Gottmann U, et al. (2008) Hypothermic injury: The mitochondrial calcium, ATP and ROS love-hate triangle out of balance. Cell Physiol Biochem 22: 195-204.
27. Tang G, Wu L, Liang W, Wang R, (2005) Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 68: 1757-1764.
28. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, et al. (2009) H2S signals through protein S-sulfhydration. Sci Signal 2: ra72.
29. Schuff-Werner P, Splettstosser W, Schmidt F, Huether G, (1995) Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of human mononuclear and polymorphonuclear phagocytes. Eur J Clin Invest 25: 477-484.
30. Banerjee R, Zou C, (2005) Redox regulation and reaction mechanism of human cystathionine-β-synthase: A PLP-dependent hemesensor protein. Arch Biochem Biophys 433: 144-156.
31. Bianchi P, Pimentel DR, Murphy MP, Colucci WS, Parini A, (2005) A new hypertrophic mechanism of serotonin in cardiac myocytes: Receptor-independent ROS generation. FASEB J 19: 641-643.
32. Pena-Silva RA, Miller JD, Chu Y, Heistad DD, (2009) Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves. Am J Physiol Heart Circ Physiol 297: H1354-60.
33. Warenycia MW, Smith KA, Blashko CS, Kombian SB, Reiffenstein RJ, (1989) Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: Increases in brain catecholamine and 5-hydroxytryptamine levels. Arch Toxicol 63: 131-136.
34. Santini E, Heiman M, Greengard P, Valjent E, Fisone G, (2009) Inhibition of mTOR signaling in parkinson's disease prevents L-DOPA-induced dyskinesia. Sci Signal 2: ra36.
35. Liu Y, Fanburg BL, (2006) Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-Kinase/Serine-threonine protein kinase B/Mammalian target of Rapamycin/p70 ribosomal S6 kinase 1. Am J Respir Cell Mol Biol 34: 182-191.
36. Finkelstein JD, (1998) The metabolism of homocysteine: Pathways and regulation. Eur J Pediatr 157 (Suppl 2): S40-4.
37. Robert K, Vialard F, Thiery E, Toyama K, Sinet PM, et al. (2003) Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J Histochem Cytochem 51: 363-371.
38. Busza AL, Fuller BJ, Lockett CJ, Proctor E, (1992) Maintenance of liver adenine nucleotides during cold ischemia. the value of a high-pH, high-pK flush. Transplantation 54: 562-565.
39. Fiddian Green RG, (1995) Gastric intramucosal pH, tissue oxygenation and acid-base balance. Br J Anaesth 74: 591-606.
40. Wolf RF, van der Hoeven JA, Kamman RL, Busza AL, Ploeg RJ, et al. (1996) Tissue pH in cold-stored human donor livers preserved in university of wisconsin solution. A noninavasive clinical study with 31P-magnetic resonance spectroscopy. Transplantation 61: 66-70.
41. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, et al. (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37: 1-31.
42. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, et al. (1995) Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia. PNAS 92: 1585-1589.
43. Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, et al. (2006) 3-deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Am J Physiol Lung Cell Mol Physiol 291: L905-911.
44. Hamelet J, Maurin N, Fulchiron R, Delabar J, Janel N, (2007) Mice lacking cystathionine beta synthase have lung fibrosis and air space enlargement. Exp Mol Pathol 83: 249-253.
45. Lin KJ, Ye XX, Yen TC, Wey SP, Tzen KY, et al. (2002) Biodistribution study of [(123)I] ADAM in mice: Correlation with whole body autoradiography. Nucl Med Biol 29: 643-650.
46. Eisenhofer G, (2001) The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91: 35-62.
47. Racagni G, Popoli M, (2010) The pharmacological properties of antidepressants. Int Clin Psychopharmacol 25: 117-131.
48. Peng YJ, Nanduri J, Raghuraman G, Souvannakitti D, Gadalla MM, et al. (2010) H2S mediates O2 sensing in the carotid body. Proc Natl Acad Sci U S A 107: 10719-10724.
49. Yang G, Wu L, Jiang B, Yang W, Qi J, et al. (2008) H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590.
50. Kawabata A, Ishiki T, Nagasawa K, Yoshida S, Maeda Y, et al. (2007) Hydrogen sulfide as a novel nociceptive messenger. Pain 132: 74-81.
51. Qu K, Lee SW, Bian JS, Low C-, Wong PT, (2008) Hydrogen sulfide: Neurochemistry and neurobiology. Neurochem Int 52: 155-165.